Open Access

Par Ahou Rachel KOUMI Ce blogpost est la deuxième partie d’une série de deux blogs sur les Journées de l’Innovation en Contexte Académique réalisées du 19...

By Helen Chuma-Okoro and Nicole Tumaine Access to knowledge (A2K) is necessary to further innovation and creativity. Due to the exclusive nature of...

Just last month, I had the opportunity to participate in the 13th WIPO-WTO Colloquium for Teachers of Intellectual Property held at World Intellectual Property Organization (WIPO) and World Trade Organization (WTO) headquarters in Geneva, Switzerland from 13 to 24 June, 2016. I am beyond thankful for this scholarship and enjoyed an intense two week programme, covering eighteen substantive topics touching on all areas of intellectual property (IP) law. There were thirty-nine experts from WIPO, WTO, WHO, UNFCCC, UPOV, NGOs ,and industry who took part in the Colloquium as speakers and I was among twenty-six participants selected from approximately 160 applicants from developing countries around the world.

Par Abdelhamid Benhmade Sans pour autant être d’un optimisme béat ni sombrer dans un pessimisme démesuré, il est clair que la dérogation aux droits de...

Jeremy de Beer, Izabella Sowa et Kristen HolmanDate de publication: septembre 2017Télécharger: Chapitre 2: Cadres d’analyse de l’innovation africaine : l’entrepreneuriat, l’économie informelle et...

This 2013 book is the product of three years of literature reviews, expert interviews and scenario-building exercises by the Open AIR network. The authors trace the contours of knowledge and innovation in Africa from the founding civilisations to today’s current realities, and then set out the drivers of change that can be expected to shape innovation systems on the continent between now and the year 2035.

Jeremy de Beer, Chidi Oguamanam et Tobias Schonwetter Date de publication : septembre 2017 Télécharger : Chapitre 1: Innovation, propriété intellectuelle et développement en Afrique (3.7MB) ...

Edited by: Chidi Oguamanam. When the oral history of a medicinal plant as a genetic resource is used to develop a blockbuster drug, how is the contribution of Indigenous Peoples recognized in research and commercialization? What other ethical, legal, and policy issues come into play? Is it accurate for countries to self-identify as users or providers of genetic resources?

Jeremy de Beer, Chris Armstrong, Chidi Oguamanam et Tobias Schonwetter Date de publication : septembre 2017 Télécharger: Chapitre 16 : La propriété intellectuelle...

Par Abdelhamid Benhmade En réponse à l’invitation de Cités et Gouvernements Locaux Unis d’Afrique (CGLU Afrique), j’ai eu la possibilité d’assister à la 8èmeédition du...